Gad Berdugo
Director/Board Member at Diaccurate SA
Profile
Gad Berdugo was the founder of Explorium Capital LLC (founded in 2008) and Epivax Oncology, Inc. (founded in 2017), where he held the titles of Managing Partner and Chief Executive Officer & Director, respectively.
He is currently an Independent Director at Diaccurate SA. Mr. Berdugo's former positions include Director-Global Business Development at Baxter Healthcare Corp., Director at Genome Profiling LLC, Equity Analyst at Lazard Asset Management LLC, and Managing Director & Head-Life Sciences at Tegris Corp.
He was also the CFO, Secretary & Executive VP-Administration at Immune Pharmaceuticals, Inc. from 2014 to 2015 and the Chief Business Officer at Editas Medicine, Inc. from 2020 to 2021.
Mr. Berdugo received his undergraduate degree from Imperial College London, his graduate degree from University College London, and his MBA from École des Hautes Études Commerciales de Paris.
Gad Berdugo active positions
| Companies | Position | Start |
|---|---|---|
Diaccurate SA
 Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Director/Board Member | - |
Former positions of Gad Berdugo
| Companies | Position | End |
|---|---|---|
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 2021-07-25 |
Epivax Oncology, Inc.
 Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Founder | 2020-05-31 |
| IMMUNE PHARMACEUTICALS, INC. | Director of Finance/CFO | 2015-12-30 |
Explorium Capital LLC
 Explorium Capital LLC Investment ManagersFinance Founded in 2008 by Gad Berdugo, Explorium Capital LLC is a hedge fund manager located in New York City. | Founder | 2011-12-31 |
| MABCURE INC | Director/Board Member | 2011-06-01 |
Training of Gad Berdugo
| Imperial College London | Undergraduate Degree |
| University College London | Graduate Degree |
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MABCURE INC | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Lazard Asset Management LLC
 Lazard Asset Management LLC Investment ManagersFinance Lazard Asset Management LLC (LAM) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 1970 and is a wholly-owned subsidiary of Lazard Frères & Co. LLC, ultimately held by Lazard Ltd. (NYSE: LAZ). LAM provides investment advisory services to a variety of clients. | Finance |
| Tegris Corp. | |
Explorium Capital LLC
Explorium Capital LLC Investment ManagersFinance Founded in 2008 by Gad Berdugo, Explorium Capital LLC is a hedge fund manager located in New York City. | Finance |
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Genome Profiling LLC
 Genome Profiling LLC Packaged SoftwareTechnology Services Genome Profiling LLC provides software platform to discover novel epigenetic biomarkers. The firm offers its services to researchers and clinicians to tailor diagnostics and therapies for the needs of individual patients. The company was founded by Jeb Connor and Adam Marsh and is headquartered in Wayne, PA. | Technology Services |
Epivax Oncology, Inc.
Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Health Technology |
Diaccurate SA
Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Gad Berdugo
